Markets.com Logo
markets.com

EDIT

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2.6221$
  • Previous Close
    2.7456$
  • 52 Week Change
    3.21$
  • Day Range
    -0.12$
  • 52 Week High/Low
    0.9101$ - 4.12$
  • Dividend Per Share
    --
  • Market cap
    240 M$
  • EPS
    -0.63
  • Beta
    2.197
  • Volume
    --

About

EDIT.US is the stock ticker symbol for Editas Medicine, a biotechnology company focused on developing CRISPR-based gene editing therapies for serious diseases. The ".US" suffix indicates that the stock is listed on a U.S. stock exchange, specifically the NASDAQ. Editas Medicine is pioneering the development of potentially curative medicines based on its gene editing technology.
markets.com
Dogecoin Price Forecast 2026–2030: Can DOGE Reach $1?

Dogecoin Price Forecast 2026–2030: Can DOGE Reach $1?

Julian Parker|--
Solana Price Prediction 2026, 2030 & 2040: How High Can SOL Go?

Solana Price Prediction 2026, 2030 & 2040: How High Can SOL Go?

Daniel Carter|--
Nvidia Q2 Earnings Preview: Can $92 Billion Revenue End NVDA’s Seven-Day Slide?

Nvidia Q2 Earnings Preview: Can $92 Billion Revenue End NVDA’s Seven-Day Slide?

Julian Parker|--
Ethereum (ETH) Price Prediction 2026-2030: Can ETH Break $3,000 After a 33% Weekly Rally?

Ethereum (ETH) Price Prediction 2026-2030: Can ETH Break $3,000 After a 33% Weekly Rally?

Julian Parker|--
Coinbase Stock Forecast 2026–2030: Can COIN Recover as Bitcoin Nears $80,000?

Coinbase Stock Forecast 2026–2030: Can COIN Recover as Bitcoin Nears $80,000?

Julian Parker|--
Cryptos shine again, USD on the edge

Cryptos shine again, USD on the edge

Darius Anucauskas|--
Samsung Stock Forecast: Can AI Memory Demand Offset the Latest Sell-Off?

Samsung Stock Forecast: Can AI Memory Demand Offset the Latest Sell-Off?

Julian Parker|--

Factors

Company Performance: Revenue, earnings, and clinical trial results significantly impact investor confidence.

Market Sentiment: Overall investor mood and broader market trends influence trading activity.

Regulatory News: FDA decisions regarding gene editing therapies can cause substantial price fluctuations.

Competition: Progress or setbacks by competitors in the gene editing space affect Editas's valuation.

Partnerships: Collaborations and licensing agreements can signal future revenue and innovation.

Economic Conditions: Interest rates and macroeconomic factors can indirectly influence investment decisions.

People Also Watch

Latest news

Bitcoin Price Surges Past $80,000 as ‘Debasement Trade’ Returns

Bitcoin Price Surges Past $80,000 as ‘Debasement Trade’ Returns

Julian Parker|--
Nvidia Stock Rises 2.19% as $280bn Earnings Swing Looms

Nvidia Stock Rises 2.19% as $280bn Earnings Swing Looms

Julian Parker|--
Oil Price Today: WTI Falls 2.6% to $80.20 on Hormuz Deal Hopes

Oil Price Today: WTI Falls 2.6% to $80.20 on Hormuz Deal Hopes

Julian Parker|--

Latest Education Articles

Top Meme Coins to Watch in 2026: A Trader’s Guide

Top Meme Coins to Watch in 2026: A Trader’s Guide

Julian Parker|--
XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

Daniel Carter|--
How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

Daniel Carter|--
Recommended Topics
markets.com